In a study recently published in Cancer Research, a journal of the American Association for Cancer Research, a team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director for the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Cancer Center, sought to expand upon his lab’s previous research that showed ALT tumors identified by a biomarker known as C-circles share a common biology that confers vulnerabilities to be exploited for cancer therapy.
Research identifies, exploits vulnerability in certain high-risk cancers
August 11, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022